American Vanguard (NYSE:AVD) Downgraded by Wall Street Zen to “Sell”

Wall Street Zen downgraded shares of American Vanguard (NYSE:AVDFree Report) from a hold rating to a sell rating in a research note published on Saturday morning.

Separately, Weiss Ratings downgraded shares of American Vanguard from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, May 18th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

View Our Latest Stock Analysis on AVD

American Vanguard Stock Down 1.2%

Shares of NYSE:AVD opened at $2.10 on Friday. American Vanguard has a 1 year low of $2.05 and a 1 year high of $5.92. The company has a market capitalization of $62.10 million, a PE ratio of -1.11 and a beta of 1.43. The business has a fifty day moving average price of $2.63 and a two-hundred day moving average price of $3.20. The company has a debt-to-equity ratio of 1.46, a current ratio of 2.47 and a quick ratio of 1.41.

American Vanguard (NYSE:AVDGet Free Report) last released its earnings results on Monday, August 10th. The basic materials company reported ($0.34) EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.43). The business had revenue of $116.75 million for the quarter, compared to the consensus estimate of $135.00 million. American Vanguard had a negative return on equity of 9.05% and a negative net margin of 10.70%.

Insiders Place Their Bets

In other news, Director Patrick E. Gottschalk acquired 25,000 shares of American Vanguard stock in a transaction on Tuesday, May 19th. The stock was acquired at an average cost of $2.70 per share, with a total value of $67,500.00. Following the completion of the acquisition, the director owned 191,705 shares in the company, valued at approximately $517,603.50. This trade represents a 15.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 5.60% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. R Squared Ltd bought a new position in shares of American Vanguard during the 1st quarter worth $28,000. Strs Ohio bought a new stake in American Vanguard in the 1st quarter valued at about $28,000. nVerses Capital LLC bought a new stake in American Vanguard in the 4th quarter valued at about $42,000. Virtu Financial LLC purchased a new stake in American Vanguard during the fourth quarter valued at about $52,000. Finally, Jain Global LLC purchased a new stake in American Vanguard during the fourth quarter valued at about $53,000. Hedge funds and other institutional investors own 79.00% of the company’s stock.

American Vanguard Company Profile

(Get Free Report)

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.

Read More

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.